Latest posts
-
PRECISION MEDICINE : Personalizing Healthcare with Genomics
PRECISION MEDICINE: Personalizing Healthcare with Genomics What if your doctor could prescribe a treatment that is tailored to your unique genetic makeup, lifestyle and environment? That is the promise of precision medicine, an emerging field that uses genomics and other data to create personalized healthcare plans. Precision medicine is not a new concept. For decades,
-
Emerging Trends in Digital Health – Wearables and IoT Devices
The healthcare industry stands at an inflection point. Wearable medical devices have transitioned from consumer novelties to clinical-grade tools, with the global market reaching USD 42.7 billion in 2024 and expected to exceed USD 152 billion by 2029, according to Grand View Research. But the real story isn’t the market size—it’s the fundamental shift in how care is
-
Demystifying AI in Drug Discovery: Transforming Pharma R&D
Demystifying AI in Drug Discovery: Transforming Pharma R&D Artificial Intelligence (AI) has swiftly transformed industries, and drug discovery is no exception. The pharmaceutical research and development (R&D) process has traditionally been lengthy, resource-intensive, and marked by high failure rates. However, with the advent of AI, a new era has dawned, promising to revolutionize the drug
-
Sandoz boosts Canadian production capacity
Sandoz boosts Canadian production capacity Sandoz Canada, a unit of Novartis’ generics arm, has opened a second manufacturing plant at its site in Boucherville, Quebec, boosting local production capacity 66 per cent. The plant, which is due to be fully operational by mid September, comprises manufacturing, laboratory and warehousing space that the firm believes will
-
Cholesterol- lowering drug given cancer all-clear
Cholesterol- lowering drug given cancer all-clear Cancer fears about a cholesterol- lowering drug have turned out to be a ‘statistical blip’. A class of cholesterol- lowering drug that had been implicated in a cancer scare has been cleared by epidemiologists using the results from two large ongoing clinical trials. Preliminary results from the relatively small
-
Big pharma’s pre-competitive collaboration
Big pharma’s pre-competitive collaboration Merck, Eli Lilly and Pfizer have provided funding to launch Enlight Biosciences, a for-profit venture that aims to advance breakthrough technologies for drug discovery and development. The lowdown: There has recently been increasing emphasis from industry on participating in non-profit collaborations to address issues in drug development that are considered to